Aneurysm II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Endocarditis II: Clinical Features of Infective Endocarditis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 12, 2026

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
1Vaskulitiszentrum Süd, Klinik für Innere Medizin, Rheumatologie und Immunologie, Klinik Kirchheim, Akademisches Lehrkrankenhaus der Universität Tübingen, Eugenstr. 3, 73230, Kirchheim u. Teck, Deutschland. b.hellmich@kk-es.de.
Recent clinical trials have updated antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) treatment strategies. This review compares four major AAV guideline recommendations, noting significant agreement but also key differences in diagnosis and management.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: